Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Non-Current Assets (2019 - 2025)

Pulmonx (LUNG) has disclosed Non-Current Assets for 7 consecutive years, with -$123.9 million as the latest value for Q1 2025.

  • On a quarterly basis, Non-Current Assets fell 844.47% to -$123.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was -$53.3 million, a 157.55% decrease, with the full-year FY2024 number at $26.6 million, down 2.77% from a year prior.
  • Non-Current Assets was -$123.9 million for Q1 2025 at Pulmonx, down from $26.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $28.7 million in Q2 2023 to a low of -$233.1 million in Q2 2021.
  • A 5-year average of -$16.7 million and a median of $22.3 million in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 98.05% in 2021, then tumbled 844.47% in 2025.
  • Pulmonx's Non-Current Assets stood at $27.2 million in 2021, then decreased by 9.01% to $24.7 million in 2022, then grew by 10.66% to $27.4 million in 2023, then fell by 2.77% to $26.6 million in 2024, then crashed by 565.9% to -$123.9 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non-Current Assets are -$123.9 million (Q1 2025), $26.6 million (Q4 2024), and $16.6 million (Q1 2024).